Description
A Deeper Look at Hidden Heart Disease Risk
Standard cholesterol tests often miss the early drivers of heart disease.
The Cardiovascular Risk – Advanced Blood Panel evaluates lipoprotein risk, inflammation, blood sugar control, and insulin resistance, providing a more complete picture of cardiovascular health than a basic lipid panel alone.
This panel is designed for individuals who want precision risk assessment, not just surface-level numbers.
Biomarkers Included
- Apolipoprotein B (ApoB) Measures the total number of atherogenic (artery-damaging) lipoprotein particles.
- Apolipoprotein A-1 (ApoA-1) The primary protein of HDL particles, reflecting protective cholesterol transport capacity.
- Lipoprotein(a) [Lp(a)] A genetically influenced risk factor strongly associated with premature cardiovascular disease.
- High-Sensitivity C-Reactive Protein (hs-CRP) Measures systemic inflammation linked to plaque instability and cardiovascular events.
- Fasting Insulin Identifies insulin resistance, a major driver of cardiometabolic and vascular disease.
- Hemoglobin A1c (HbA1c) Reflects average blood sugar control over the past 2–3 months.
Why These Markers Matter Together
Heart disease is rarely caused by cholesterol alone. This panel evaluates:
- Atherogenic particle burden and lipid balance
- Genetic cardiovascular risk
- Chronic inflammation
- Early insulin resistance and glycemic control
Together, these markers help identify hidden cardiovascular risk, even when standard cholesterol values appear normal.
This Panel Is Especially Useful If You Have:
- Family history of heart disease or stroke
- Normal LDL but ongoing cardiovascular concern
- Prediabetes or metabolic syndrome
- Type 2 diabetes
- Elevated triglycerides or low HDL
- History of insulin resistance
- Interest in preventive or longevity-focused care
Fasting
- Fasting is recommended, particularly for insulin-related markers.
